Sanofi Profit Tops Forecasts, Plans €1 Billion Share Buyback
Sanofi posted higher-than-expected quarterly profit, aided by sales of its blockbuster skin and asthma drug Dupixent, and forecast another year…
Sanofi posted higher-than-expected quarterly profit, aided by sales of its blockbuster skin and asthma drug Dupixent, and forecast another year…
Sanofi (NASDAQ:SNY) is one of the Best Affordable Stocks to Buy According to Analysts. On December 24, Sanofi (NASDAQ:SNY) announced…
Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion, as the French drugmaker tries to expand a vaccines…
Source: Bloomberg, 4:50 www.bloomberg.com #Stock #Movers #Sanofi #Fresnillo #Podcast
Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion to expand its vaccines business with a shot for…
Shares of Sanofi slumped on Monday as the French drugmaker said a U.S. regulatory review of its multiple-sclerosis drug won’t…
Sanofi (NASDAQ:SNY) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Sanofi (NASDAQ:SNY) has…
Sanofi (NASDAQ:SNY) is one of the best low volatility large cap stocks to invest in. Deutsche Bank analyst Emmanuel Papadakis maintained…
Source: Bloomberg, 4:31 www.bloomberg.com #Stock #Movers #NatWest #Sanofi #Saab #Podcast
Source: Bloomberg, 4:23 www.bloomberg.com #Stock #Movers #Sanofi #Jet2 #Burberry #Podcast